NTLA INTELLIA THERAPEUTICS
Health Care · Russell 2000
Next earnings: not announced yet
What 30 analyst firms say about INTELLIA THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
27 rated views · 32 analyst/firm records · 30 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8021
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8015
Recent analyst activity · last 90 days
Our tracked history has 10 reports on NTLA from 9 analyst firms in the last 90 days (30 firms in the past year).
Comparing each firm's latest target with its previous one: 2 lowered it and 5 left it unchanged.
Ratings, latest available report against the previous one: 0 upgrades and 1 downgrade.
Latest observed target change: Barclays lowered its target from $14.00 (set 7 Nov 2025) to $8.00 on 6 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Baird | Jack K Allen | Hold | 3 Sep 2026 | 13.00 USD |
| Bank of America Securities | Greg Harrison | Hold | 2 Mar 2026 | — |
| Barclays | Eliana Merle | Sell | 6 Oct 2026 | 8.00 USD |
| Barclays | Gena Wang | Sell | 6 Oct 2026 | 8.00 USD |
| Bernstein | William Pickering | Hold | 13 May 2026 | 17.00 USD |
| Brookline Capital Markets | Leah R Cann | Buy | 6 Aug 2026 | 61.00 USD |
| Canaccord Genuity | Whitney Ijem | Buy | 16 Jun 2026 | 49.00 USD |
| Chardan Capital Markets | Geulah Livshits | Buy | 27 Apr 2026 | 30.00 USD |
| Citigroup | Unnamed analyst | Buy | 25 Aug 2026 | — |
| Citizens JMP | Silvan C Tuerkcan | Buy | 15 Jun 2026 | 30.00 USD |
| Citizens JMP | Silvan Turkcan | Buy | 9 Sep 2026 | 30.00 USD |
| Evercore ISI | Jonathan Miller | Buy | 7 Aug 2026 | 24.00 USD |
| Goldman Sachs | Salveen Richter | Sell | 7 Aug 2026 | 9.00 USD |
| Guggenheim | Debjit Chattopadhyay | Hold | 1 Jul 2026 | — |
| H.C. Wainwright | Mitchell S. Kapoor | Buy | 9 Sep 2026 | 25.00 USD |
| Jefferies | Maury Raycroft | Buy | 1 Jul 2026 | 49.00 USD |
| Jonestrading | Debanjana Chatterjee | Buy | 4 Sep 2026 | 29.00 USD |
| JPMorgan | Brian Cheng | Sell | 7 Nov 2025 | 5.00 USD |
| KeyBanc Capital Markets | Unnamed analyst | — | 28 Jan 2026 | 25.00 USD |
| Leerink Partners | Unnamed analyst | — | 27 Apr 2026 | 35.00 USD |
| Morgan Stanley | Terence Flynn | Hold | 27 Apr 2026 | 15.00 USD |
| New Street Research | Unnamed analyst | — | 15 Jun 2026 | 25.00 USD |
| Oppenheimer | Unnamed analyst | — | 7 Nov 2025 | 27.00 USD |
| RBC Capital Markets | Luca Issi | Hold | 3 Mar 2026 | 15.00 USD |
| TD Cowen | Joseph Thome | Buy | 27 Feb 2026 | — |
| Truist | Unnamed analyst | Buy | 25 Mar 2026 | 14.00 USD · 10 Nov 2025 |
| Wedbush | David Nierengarten | Hold | 9 Sep 2026 | 13.00 USD |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| Wells Fargo | Yanan Zhu | Hold | 5 Oct 2026 | 15.00 USD |
| William Blair | Myles R Minter | Buy | 15 Jun 2026 | — |
| Wolfe Research | Andy Chen | Sell | 15 Jul 2026 | 9.00 USD |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | 14.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 05:56 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.